One of the things which I’ve now had to come to terms with since coming to the US and being diagnosed with Hodgkin’s Lymphoma is the cost of treatment so I was fascinated to discover that India has just granted a company “compulsory license” to manufacture a patented cancer drug.
According to the BBC report a company named Bayer holds the patent for a drug named Nexavar which it sells in India at a price of 280000 rupees for 120 tablets which is a little over 2333 rupees per tablet. The court has now authorised another company Natco Pharma to manufacture and sell a generic copy of the patented drug in India for the sum of 8800 rupees for 120 tablets which is a little over 73 rupees per tablet!!! This means instead of paying around $47 per pill it will only cost around $1.50!! Natco Pharmar will have to pay a 6% royalty to Bayer.